NuCana (NCNA) Current Assets (2016 - 2025)

NuCana (NCNA) reported Current Assets of $35.7 million for Q4 2025, up 126.97% on a YoY basis from $15.7 million in Q4 2024, and down 11.26% sequentially from $40.3 million in Q3 2025.

NuCana (NCNA) Current Assets (2016 - 2025) Analysis & Trends

NuCana (NCNA) has 10 years of Current Assets data on file, last reported at $35.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 126.97% year-over-year to $35.7 million; the trailing twelve-month figure through Dec 2025 stood at $35.7 million (up 126.97% YoY), and the FY2025 full-year result was $35.4 million, up 125.9% from the prior year.
  • Current Assets slipped to $35.7 million in Q4 2025, from $40.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $131.0 million in Q1 2021 to a low of $11.5 million in Q1 2025.
  • A 5-year average of $56.4 million and a median of $43.8 million in 2023 frame the typical range for Current Assets.
  • Peak annual rise in Current Assets reached 126.97% in 2025, while the deepest fall reached 58.95% in 2025.
  • Tracing NCNA's Current Assets over 5 years: stood at $96.5 million in 2021, then slumped by 33.27% to $64.4 million in 2022, then sank by 51.79% to $31.1 million in 2023, then plunged by 49.3% to $15.7 million in 2024, then surged by 126.97% to $35.7 million in 2025.
  • Business Quant data shows NCNA's Current Assets at $35.7 million in Q4 2025, $40.3 million in Q3 2025, and $18.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 289.93 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 73.04 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 6.60 Bn
4 NuCana 279.75 Bn 279.75 Bn - 35.73 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 11.73 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 18.21 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 521.86 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 8.07 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.97 Bn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 4.22 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 35.73 Mn
Sep 30, 2025 40.26 Mn
Jun 30, 2025 18.32 Mn
Mar 31, 2025 11.48 Mn
Dec 31, 2024 15.74 Mn
Sep 30, 2024 21.93 Mn
Jun 30, 2024 21.89 Mn
Mar 31, 2024 27.97 Mn
Dec 31, 2023 31.05 Mn
Sep 30, 2023 38.82 Mn
Jun 30, 2023 47.41 Mn
Mar 31, 2023 55.16 Mn
Dec 31, 2022 64.42 Mn
Sep 30, 2022 73.57 Mn
Jun 30, 2022 76.65 Mn
Mar 31, 2022 87.98 Mn
Dec 31, 2021 96.54 Mn
Sep 30, 2021 112.08 Mn
Jun 30, 2021 120.81 Mn
Mar 31, 2021 130.95 Mn